The ARRIVE Guidelines for Animal Research: Implementation and Compliance

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• The ARRIVE 2.0 guidelines (2020 revision) mandate a structured checklist for reporting in vivo animal research to enhance transparency, methodological rigor, and reproducibility, addressing documented issues of research waste and non-replicability stemming from incomplete reporting.
• ARRIVE 2.0 distinguishes between an "Essential 10" minimum reporting requirement for all animal studies and a "Recommended Set" for contextual information, facilitating practical implementation by authors, editors, and reviewers.
• Key reporting areas include detailed descriptions of study design (experimental unit, randomisation, blinding), sample size determination (effect size, variability, statistical approach), inclusion/exclusion criteria, and outcome measures to enable critical evaluation and replication.
• For veterinary research, specific considerations include reporting breed, production system, housing density, concurrent medications, and welfare-related assessments, aligning with international standards like WOAH for production animals and professional guidelines for companion animals.
• Common pitfalls in ARRIVE compliance involve superficial checklist completion without substantive methodological detail, retrospective rationalization of sample size, and conflation of reporting requirements with experimental conduct, necessitating prospective record-keeping and verification.
• The guidelines complement, but do not replace, sound experimental design and statistical practice, and their effectiveness relies on consistent enforcement by journals and institutions to prevent research waste and improve the scientific record.

The ARRIVE guidelines, Animal Research: Reporting of In Vivo Experiments, provide a structured checklist for reporting animal studies in the scientific literature. Originally published in 2010 and revised as ARRIVE 2.0 in 2020, the guidelines aim to improve the transparency, methodological rigour, and reproducibility of publications describing in vivo experiments ARRIVE 2.0 guideline update. This article serves veterinary researchers who design, conduct, or publish animal studies, and it answers the practical question of how to implement the guidelines in manuscript preparation, peer review, and institutional oversight.

The rationale for the guidelines rests on a documented problem. Incomplete reporting of animal research wastes resources and undermines the scientific record. Studies of published trial reports have shown that poor description of interventions rendered 40 to 89 percent of them non-replicable, and comparisons of protocols with publications found that most studies had at least one primary outcome changed, introduced, or omitted waste from incomplete research reports. The ARRIVE guidelines were developed to address these failures by specifying the minimum information that publications must include ARRIVE 2.0 reporting standard.

At a Glance

Historical Development of the Guidelines

The original ARRIVE guidelines emerged in 2010 from a collaboration led by the National Center for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) in the United Kingdom original ARRIVE publication. The checklist was designed to be used across biomedical disciplines, including veterinary research, and to apply to all in vivo experiments regardless of species or study design ARRIVE 2.0 reporting standard.

Despite widespread endorsement by funders and journals, adherence to the original guidelines remained inconsistent, and the anticipated improvements in reporting quality were not achieved ARRIVE 2.0 guideline update. This failure prompted a revision process that produced ARRIVE 2.0 in 2020. The update used a Delphi exercise to prioritize checklist items and reorganised the information to facilitate practical use ARRIVE 2.0 guideline update.

The Structure of ARRIVE 2.0

ARRIVE 2.0 divides the checklist into two sets. The Essential 10 constitutes the minimum requirement for any publication describing animal research. The Recommended Set describes the research context and supports a stepwise approach to implementation ARRIVE 2.0 guideline update.

This division serves a practical purpose. Journal editors and reviewers can verify that the most important items are reported in manuscripts without requiring full compliance with every recommended element at the first stage of assessment ARRIVE 2.0 guideline update. The Essential 10 items cover study design, sample size, inclusion and exclusion criteria, randomisation, blinding, outcome measures, statistical methods, experimental animals, experimental procedures, and results.

The Recommended Set includes additional items such as the abstract, background, objectives, ethical statements, housing and husbandry, welfare-related assessments, interpretation, generalizability, and protocol registration ARRIVE 2.0 reporting standard. Authors should consult the current checklist and the Explanation and Elaboration document when preparing manuscripts, because the E&E provides the rationale behind each item and practical examples of compliant reporting ARRIVE 2.0 guideline update.

Scientific Rationale for Structured Reporting

The scientific case for structured reporting rests on the principle that a research publication must allow readers to scrutinise the work adequately, evaluate its methodological rigour, and reproduce the methods and results ARRIVE 2.0 guideline update. Incomplete reports fail on all three counts.

For veterinary research specifically, the stakes include both scientific validity and animal welfare. A report that omits the number of animals used, the reasons for exclusion, or the method of randomisation cannot be evaluated for bias. A report that fails to describe housing conditions, environmental enrichment, or humane endpoints cannot be reproduced in another laboratory. The ARRIVE guidelines address these omissions directly by requiring explicit statements for each checklist item ARRIVE 2.0 reporting standard.

The guidelines also align with broader efforts to reduce research waste. Reporting guidelines such as CONSORT, STARD, PRISMA, and ARRIVE aim to improve the quality of research reports, but all are much less adopted and adhered to than they should be waste from incomplete research reports. The ARRIVE 2.0 revision was designed to counter this pattern by making the checklist easier to use and by distinguishing essential from recommended items ARRIVE 2.0 guideline update.

Relationship to Other Reporting Guidelines

ARRIVE is one of several reporting guidelines catalogued by the EQUATOR Network, which maintains a comprehensive library of health research reporting standards including CONSORT for randomised trials, PRISMA for systematic reviews, STROBE for observational studies, and REFLECT for livestock studies EQUATOR reporting guidelines. Veterinary researchers should select the guideline that matches their study design and use ARRIVE as the baseline for all in vivo work.

The guidelines are not jurisdiction-specific. They apply to animal research conducted in any country and are compatible with local regulatory frameworks. Researchers should note that compliance with ARRIVE does not substitute for compliance with institutional animal care and use committee requirements, national legislation, or international standards such as those published by the World Organization for Animal Health for animal welfare and research oversight WOAH terrestrial animal health standards.

Limitations and Ongoing Challenges

The evidence base for the effectiveness of ARRIVE is still developing. The original guidelines did not produce the expected improvements in reporting quality, and the impact of ARRIVE 2.0 has not yet been fully evaluated ARRIVE 2.0 guideline update. Adherence remains inconsistent across journals and disciplines, and enforcement depends heavily on the willingness of editors and reviewers to require compliance waste from incomplete research reports.

Another limitation is that the guidelines describe what to report, not how to conduct the research. A study with poor methodology can be reported completely and transparently. The guidelines therefore complement, instead of replace, sound experimental design and statistical practice.

Practical Implementation of the ARRIVE Essential 10

The ARRIVE Essential 10 constitutes the minimum reporting requirement for any manuscript describing in vivo experiments. These ten items were prioritized through a Delphi exercise involving researchers, journal editors, statisticians, and funders, and they represent the elements most frequently absent from published reports and most critical to evaluating methodological rigour The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. For the veterinary researcher, each item carries specific practical considerations that differ from those in biomedical research using rodents.

Study Design and Allocation

The study design item requires specification of the experimental unit, the number of experimental groups, and whether any animals were excluded from analysis. The experimental unit is the entity randomised to a treatment, and it is not always the individual animal. In a pen-based feeding trial in pigs, the pen is the experimental unit even though measurements are taken from individual animals. Confusing the observational unit with the experimental unit leads to pseudoreplication and inflated precision. The ARRIVE 2.0 Explanation and Elaboration document provides worked examples of correctly identifying experimental units across common designs The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research.

Allocation concealment and blinding must be described at a level of detail sufficient for replication. State who generated the allocation sequence, who enrolled animals, and who assigned them to groups. In veterinary field trials, complete blinding is often impossible because of visible differences between treatment groups, such as surgical incisions versus sham procedures. Describe partial blinding explicitly and state which outcomes were assessed by blinded personnel. A common pitfall is reporting that the study was blinded without specifying which parties were masked.

Sample Size and Inclusion Criteria

The sample size item requires reporting how the number of animals was determined, including the effect size targeted, the variability estimate used, and the statistical approach. If sample size was determined by availability instead of power calculation, state this directly. Many veterinary studies, particularly those using client-owned animals, are constrained by caseload. Acknowledging this limitation is preferable to omitting the information or presenting a post hoc justification.

The inclusion and exclusion criteria item requires pre-specified criteria for enrollment and for removal from the study or analysis. Distinguish between animals withdrawn because of adverse events, animals removed because of protocol violations, and animals excluded as statistical outliers. Report the number of animals in each category. The timing of exclusion matters: excluding animals after randomisation but before analysis can introduce bias if the exclusion relates to treatment response. Pre-specifying criteria in the study protocol, before data collection begins, is the most effective safeguard.

Randomisation and Blinding

Randomisation reporting must describe the method used to generate the random sequence and the mechanism of allocation. Common methods include random number tables, computer-generated sequences, and stratified randomisation for variables such as body weight, age, or baseline disease severity. Stratification is particularly relevant in veterinary studies where breed, sex, and body condition score influence outcomes. Describe the strata and the allocation ratio within each stratum.

Blinding reporting must specify which individuals were blinded to group assignment. In veterinary research, the animal cannot be blinded, but the owner, the clinician administering treatment, the outcome assessor, and the statistician can each be blinded independently. A common pitfall is blinding only the outcome assessor while the person administering the treatment also performs the outcome measurements. Describe the blinding status of each role separately.

The Recommended Set in Veterinary Contexts

The Recommended Set comprises additional items that provide research context and facilitate interpretation. These items are not optional in the sense of being unimportant, they are separated from the Essential 10 to support a stepwise implementation approach for journals and reviewers The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. Veterinary manuscripts should include these items whenever they are relevant to the species and study type.

Animals, Husbandry, and Welfare

The animals item requires reporting species, strain or breed, sex, age or developmental stage, weight, and health or immune status. For companion animal studies, client-owned animals introduce heterogeneity that laboratory animals do not. Report breed distributions, body condition scores, and any concurrent medications. For production animals, report the production system, housing density, and nutritional plane. These details affect generalizability and allow readers to assess whether findings apply to their own patient populations.

The husbandry item covers housing, temperature, light-dark cycle, access to food and water, and environmental enrichment. For agricultural species, report stocking density, flooring type, and ventilation parameters. For laboratory species, report cage type, bedding, and social housing status. The welfare-related assessments and interventions item requires reporting of the methods used to assess animal welfare and any interventions applied to minimize suffering. This includes humane endpoints, analgesic protocols, and monitoring frequency. WOAH terrestrial animal health standards provide international reference points for welfare assessment in production species, and veterinary researchers should align their reporting with these standards where applicable.

Interpretation and Generalizability

The interpretation section requires authors to describe the results in the context of the study objectives and to state the implications for future research and clinical practice. For veterinary research, this includes discussing how findings might translate across species, across production systems, or from experimental models to client-owned patients. The generalizability item requires explicit discussion of the extent to which the findings can be extrapolated beyond the study population. A study in purpose-bred beagles may not generalize to client-owned dogs of diverse breeds and ages. State these limitations directly instead of implying universal applicability.

Common Pitfalls in ARRIVE Compliance

The most frequent compliance failures in animal research reporting have been documented since the original guidelines were published. Incomplete descriptions of interventions render a substantial proportion of published studies non-replicable, and primary outcomes are frequently changed, introduced, or omitted between protocol and publication Reducing waste from incomplete or unusable reports of biomedical research. These failures persist despite journal endorsement of the guidelines.

Species-Specific Reporting Considerations

The correct application of ARRIVE items varies by species and production system. In companion animal oncology trials, client-owned animals present with naturally occurring disease, and the reporting of prior treatments, concurrent medications, and disease stage is essential for interpretation. In food animal research, the production system, whether intensive or extensive, pasture-based or confinement, affects both the biology under study and the generalizability of findings. In equine research, the distinction between experimental horses and client-owned horses under training affects the reporting of exercise history and musculoskeletal status.

The equipment and consumables available to the research group also shape what can be reported. A study using advanced imaging can report standardized acquisition parameters, while a study relying on physical examination findings must report the examiner's experience and the criteria used to assign clinical scores. The ARRIVE guidelines do not mandate specific technologies, they mandate transparent description of what was actually done The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. Where the evidence base is limited, such as in wildlife research where randomisation is often impossible, authors should state the constraints and describe the observational design used in place of an experimental one.

Recognized Complications and Failure Modes

The most frequently observed failure in ARRIVE implementation is checklist completion without substantive reporting change. Authors may tick every box while omitting the actual methodological detail the item demands. A second common failure is selective application, where randomisation and blinding are reported for outcome assessment but omitted for allocation, or where sample size justification appears only as a post hoc power calculation. The ARRIVE 2.0 guidelines were restructured specifically because adherence to the original 2010 checklist had been inconsistent and the anticipated improvements in reporting quality had not materialised.

A third failure mode is retrospective compliance. Manuscripts drafted without reference to the checklist are revised at submission to appear compliant, which produces vague statements such as "animals were randomly assigned" without specifying the method, sequence generation, or allocation concealment. This pattern is detectable during peer review when the methods section lacks operational detail. A fourth failure is the conflation of reporting with conduct. The guidelines improve the transparency of what was done, they cannot correct deficient experimental design that has already occurred. Journals that mandate ARRIVE but do not verify content against the checklist perpetuate this problem.

Early detection of these failures requires structured verification instead of casual reading. Editors and reviewers should compare each Essential 10 item against a specific sentence or data element in the manuscript. The Explanation and Elaboration document provides the rationale behind each item and the level of detail expected, which gives reviewers a concrete standard against which to judge compliance.

Common Errors by Less Experienced Researchers

Early-career investigators frequently mistake the Essential 10 for a complete methods section. The Essential 10 constitutes the minimum requirement, while the Recommended Set describes the research context needed for full evaluation and replication. Omitting the Recommended Set does not violate the minimum standard but limits the scientific value of the report.

A recurring error is the treatment of exclusion criteria. Novice authors report the number of animals excluded but not the criteria that triggered exclusion, the timing of exclusion relative to intervention, or whether exclusion decisions were made blind to treatment group. The corrective action is to report exclusion criteria prospectively in the methods and to state whether any animals were removed after the experiment began.

Another common error concerns the distinction between experimental units and observational units. Students often report the number of observations instead of the number of independently allocated experimental units, which inflates the apparent sample size. The corrective action is to identify the unit of randomisation explicitly and to report the number of units, not the number of measurements, in the sample size statement.

A third error is the use of imprecise welfare language. Statements such as "animals were humanely euthanised" without specifying the method, the criteria that triggered euthanasia, or the person making the decision fail the welfare item of the checklist. The corrective action is to describe the monitoring schedule, the humane endpoints used, and the method of euthanasia in sufficient detail for replication.

Limitations of the Current Evidence

The evidence base for ARRIVE effectiveness is thinner than its endorsement suggests. The original guidelines were published in 2010, and the 2020 revision followed a Delphi exercise to prioritize items, but longitudinal data demonstrating sustained improvement in reporting quality across journals remain limited. The 2014 analysis of research waste documented substantial failures in the reporting of interventions, primary outcomes, and prior evidence, and noted that reporting guidelines including ARRIVE were much less adopted and adhered to than they should be.

Expert opinion still differs on whether journal endorsement alone can drive compliance. Some editors argue that checklist submission at manuscript intake is sufficient, while others maintain that only post-acceptance verification against the full text changes author behavior. A related point of disagreement concerns the burden placed on authors. The division of items into the Essential 10 and the Recommended Set was intended to support a stepwise approach to implementation, but some reviewers apply the Recommended Set as if it were mandatory, which creates inconsistency in editorial decisions.

There is also genuine uncertainty about how ARRIVE applies to studies that are not hypothesis-testing experiments. Descriptive studies, method validations, and pilot work do not fit the randomisation and blinding items cleanly. The guidelines were designed for in vivo experiments, and their application to observational or exploratory veterinary studies requires judgment that the published guidance does not fully resolve.

Escalation and Referral Pathways

Most ARRIVE compliance problems are resolved at the manuscript level through revision and re-review. Escalation is warranted when a manuscript contains evidence of undeclared animal welfare compromise, such as the use of humane endpoints that contradict the institution's approved protocol, or when the reported methods cannot be reconciled with the stated sample size. In those circumstances, the journal editor should contact the corresponding author's institutional animal care and use committee or its national equivalent.

Regulatory reporting obligations vary by jurisdiction and species. Researchers working with production animals should consult the WOAH terrestrial animal health standards for disease surveillance and welfare requirements that may apply to experimental animals. Companion animal researchers should verify that their protocols meet the professional standards described in AVMA practice resources, which include position statements on euthanasia methods and animal welfare that journals commonly expect authors to cite.

Referral to a laboratory animal veterinarian or a biostatistician is appropriate when the research team lacks the expertise to describe anesthesia, analgesia, or sample size calculations at the level of detail ARRIVE requires. This referral should occur during protocol design, not during manuscript revision, because the missing information often cannot be recovered after the experiment has ended. Specialist consultation is also indicated when a study involves a species for which normal physiological ranges or husbandry standards are not well established in the peer-reviewed literature, the MSD Veterinary Manual provides species-specific reference values that can anchor such descriptions.

Frequently Asked Questions

How Much Time and Resources Are Required to Achieve ARRIVE Compliance?

The resource burden is modest relative to the cost of the experiments themselves. The ARRIVE 2.0 guidelines were deliberately restructured so that the Essential 10 items can be verified quickly by editors and reviewers, while the Recommended Set provides context that most well-run laboratories already collect. The main investment is prospective, not retrospective. Allocating 30 to 60 minutes during protocol design to document sample size justification, randomisation procedures, and blinding strategies prevents the far more costly process of reconstructing methods after data collection. For groups with limited administrative support, free templates and the Explanation and Elaboration document provide worked examples. Institutions that embed checklist completion into ethics approval workflows report lower overall burden than those treating compliance as a manuscript-stage afterthought.

What Should I Do When the Ideal Equipment or Facilities Are Unavailable?

Report the constraint explicitly instead of omitting it. The ARRIVE 2.0 reporting standard requires transparent description of what was done, including deviations from ideal practice. If dedicated climate-controlled housing is unavailable, state the ambient temperature range, ventilation method, and any seasonal variation. If automated randomisation software is inaccessible, describe the manual method, such as shuffled sealed envelopes, and confirm that allocation concealment was maintained. Reviewers assess methodological rigour, not perfection. A clear account of a limitation, with its potential impact on interpretation, is scientifically more valuable than silent omission. The waste from incomplete reporting arises when readers cannot determine whether a constraint affected results. Documenting the constraint allows readers to judge that question for themselves.

How Do ARRIVE Requirements Differ for Client-Owned Animals Versus Purpose-Bred Research Animals?

The core reporting obligations are identical, but the practical challenges differ substantially. For client-owned animals, randomisation and blinding may be constrained by owner preferences, concurrent medication, and variable disease stage. The ARRIVE 2.0 guidelines require that these deviations be described, including how they were managed analytically. Husbandry reporting shifts from standardized laboratory conditions to detailed descriptions of home environments, exercise, diet, and concurrent treatments. Sample size calculations must account for higher expected attrition from owner withdrawal or loss to follow-up. Welfare reporting should address the ethical framework governing client-owned subjects, which may differ from laboratory animal regulations. The WOAH terrestrial animal health standards provide relevant international context for studies involving production animals, where reporting expectations may also align with trade-related health surveillance requirements.

What Records Should I Maintain During the Study to Simplify Later ARRIVE Compliance?

Maintain a prospective study log that captures each Essential 10 item as the experiment progresses. Record the date of ethics approval, the approved protocol number, and any amendments. Document animal source, strain or breed, age, sex, and health status at enrollment. Log the exact number of animals allocated to each group, the randomisation sequence generation method, and who implemented allocation. Record which personnel were blinded to group assignment and when blinding was broken. Note any exclusions, with reasons, at the time they occur. Keep environmental monitoring data, including temperature and light cycles, where relevant. The ARRIVE 2.0 guidelines emphasize that reporting quality depends on data captured contemporaneously. Retrospective reconstruction from memory or incomplete laboratory notebooks is the most common cause of missing items. A template aligned to the checklist, completed weekly, reduces end-of-study workload.

How Should I Explain ARRIVE Compliance to a Supervisor or Collaborator Who Sees It as Bureaucratic Overhead?

Frame compliance as an investment in scientific credibility and reproducibility. The original ARRIVE publication established that transparent reporting allows others to scrutinise methodological rigour and reproduce methods. Incomplete reports waste the resources invested in the research itself, as analyzes of biomedical reporting failures have demonstrated. Poorly described interventions are frequently non-replicable, which undermines the value of the work regardless of its results. Emphasize that many journals now require the checklist at submission, so non-compliance creates avoidable revision cycles. For supervisors concerned about time, note that the Essential 10 items represent the minimum information needed to evaluate a study, not an exhaustive administrative exercise. The ARRIVE 2.0 structure was specifically designed to support a stepwise implementation approach.

What Are the Consequences of Submitting a Manuscript That Does Not Meet ARRIVE Requirements?

The most immediate consequence is editorial rejection or mandatory revision. Journals that endorse the ARRIVE guidelines typically require the completed checklist at submission, and reviewers are instructed to verify that Essential 10 items are present. Missing items often trigger requests for additional analysis or, where data were never collected, an inability to publish. Beyond the immediate submission outcome, non-compliant manuscripts contribute to the broader problem of unusable research reports, where findings cannot be replicated or synthesised into systematic reviews. This reduces the citation impact and scientific influence of the work. For veterinary research specifically, poor reporting also limits translation into clinical practice, because practitioners cannot assess whether study findings apply to their patients. Compliance is therefore a professional responsibility, also an administrative hurdle.

Related Clinical & Scientific Guides

• Conducting Systematic Reviews of Veterinary Diagnostic Test Accuracy
• Bias in Veterinary Research: Types, Sources, and Mitigation
• Cluster Randomized Trials in Veterinary Research: Design and Analysis

References and Further Reading

• The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research.. 2020.
• The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research.. 2020.
• Reducing waste from incomplete or unusable reports of biomedical research.. 2014.
• The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research.. 2020.
• Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research.. 2010.
• Animal research: reporting in vivo experiments: the ARRIVE guidelines.. 2010.
• ARRIVE Guidelines 2.0 for Reporting Animal Research. PLOS Biology, 2020.
• EQUATOR Network Reporting Guidelines. EQUATOR Network.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.

Related Articles

• Reporting Guidelines for Veterinary Research: CONSORT, STROBE, and Beyond
• Using Mixed Methods in Veterinary Research
• Conducting Qualitative Research in Veterinary Settings
• How to Write a Research Protocol for Veterinary Studies
• Applying Competing Risks Analysis in Veterinary Research

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.